EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cholesterol Functionalized Nanoparticles Are Effective against Helicobacter pylori , the Gastric Bug: A Proof‐of‐Concept Study

Ana Sofia Pinho, Renato Pereira, Mariana Pereira, Akhilesh Rai, Lino Ferreira, Maria Cristina Lopes Martins iD, Paula Parreira

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202404065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Ana Sofia Pinho und 6 weiteren Autor:innen. Beteiligte Einrichtung: i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, R. Alfredo Allen 208, Porto, 4200-135, Portugal. Hauptthemen laut MEDLINE: Helicobacter pylori, Cholesterol, Anti-Bacterial Agents, Metal Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020, Health from Portugal, FCT-Fundação para a Ci ência e Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori chronic infection is the highest risk factor for the development of gastric cancer, being this Gram‐negative bacterium classified as carcinogenic. The mounting resistance of H. pylori to antibiotics calls for innovative therapeutic strategies. Here, the proof‐of‐concept studies that support the development of a “trojan horse” therapeutic strategy based on cholesterol‐grafted nanoparticles (Chol‐NP) to counteract H. pylori infection are depicted. The bacterium ability to specifically recognize and bind to surface grafted cholesterol is demonstrated by its adhesion to cholesterol(Chol)‐functionalized self‐assembled monolayers (SAMs) on gold substrates (2D Chol‐SAMs) in a concentration dependent manner, with optimal Chol‐SAMs prepared with 25% Chol‐polyethylene glycol (PEG)‐thiol in solution (75% tetra(ethylene glycol)‐thiol). These results further show that cholesterol functionalized gold nanoparticles (3D Chol‐SAMs, Chol‐NP) eradicate H. pylori at a minimum bactericidal concentration of 125 µg mL −1 . Chol‐NP kill H. pylori through internalization and membrane rupture, as observed by transmission electron microscopy (TEM). Chol‐NP are cytocompatible (human gastric adenocarcinoma (AGS) cell line), non‐hemolytic and innocuous to bacteria representative of the gut microbiota ( Escherichia coli and Lactobacillus acidophilus ). This study supports the further development of cholesterol functionalized biomaterials as an advanced and targeted treatment for H. pylori infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriCholesterolAnti-Bacterial AgentsMetal NanoparticlesHelicobacter InfectionsHumansGoldPolyethylene GlycolsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Helicobacter pyloriantibiotic‐free strategiesbioengineeringgold nanoparticleslipidsself‐assembled monolayers

Substanzen

CholesterolAnti-Bacterial AgentsGoldPolyethylene Glycols

Autor:innen und Institutionen

  • i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, R. Alfredo Allen 208, Porto, 4200-135, Portugal.
  • INEB - Instituto de Engenharia Biomédica, Universidade do Porto, R. Alfredo Allen 208, Porto, 4200-135, Portugal.
  • ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Rua Jorge de Viterbo Ferreira 228, Porto, 4050-313, Portugal.
  • FEUP - Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias, Porto, 4200-465, Portugal.
  • CNC - Centro de Neurociências e Biologia Celular, Universidade de Coimbra, Rua Larga, 3004-504, Portugal.
  • FMUC - Faculdade de Medicina, Universidade de Coimbra, Azinhaga de Santa Comba (Celas), 3000-548, Portugal.

ORCID-Profile: Maria Cristina Lopes Martins

Förderung

  • European Union's Horizon 2020
  • Health from Portugal
  • FCT-Fundação para a Ci ência e Tecnologia

Zitieren

APA

Pinho, A. S., Pereira, R., Pereira, M., Rai, A., Ferreira, L., Martins, M. C. L., & Parreira, P. (2025). Cholesterol Functionalized Nanoparticles Are Effective against Helicobacter pylori , the Gastric Bug: A Proof‐of‐Concept Study. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404065

Vancouver

Pinho AS, Pereira R, Pereira M, Rai A, Ferreira L, Martins MCL, et al. Cholesterol Functionalized Nanoparticles Are Effective against Helicobacter pylori , the Gastric Bug: A Proof‐of‐Concept Study. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404065

BibTeX
@article{Pinho2025,
  author = {Pinho, Ana Sofia and Pereira, Renato and Pereira, Mariana and Rai, Akhilesh and Ferreira, Lino and Martins, Maria Cristina Lopes and Parreira, Paula},
  title = {Cholesterol Functionalized Nanoparticles Are Effective against Helicobacter pylori , the Gastric Bug: A Proof‐of‐Concept Study},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202404065}
}
Kostenlos starten →